KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Michael Kauffman on Q2 2020 Results - Earnings Call Transcript
Karyopharm Therapeutics, Inc. (KPTI)
Q2 2020 Earnings Conference Call
August 04, 2020, 08:30 ET
Company Participants
Ian Karp - VP, Investor & Public Relations
Michael Kauffman - Co-Founder, CEO & Director
John Demaree - Chief Commercial Officer
Michael Mason - SVP, CFO & Treasurer
Sharon Shacham - Co-Founder, President, Chief Scientific Officer & Co-Chairman, Scientific Advisory Board
Christopher Primiano - EVP, Chief Business Officer, General Counsel & Secretary
Conference Call Participants
Maurice Raycroft - Jefferies
Michael Ulz - Robert W. Baird & Co.
Peter Lawson - Barclays Bank
Eric Joseph - JPMorgan Chase & Co.